[HTML][HTML] Targeting attenuated interferon-α to myeloma cells with a CD38 antibody induces potent tumor regression with reduced off-target activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell… - PLoS …, 2016 - journals.plos.org
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
[PDF][PDF] Targeting Attenuated Interferon-αto Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regressionwith ReducedOff-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell - PLoS ONE, 2016 - scienceopen.com
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
Targeting Attenuated Interferon-[alpha] to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell… - PLoS ONE, 2016 - go.gale.com
Interferon-[alpha](IFN [alpha]) has been prescribed to effectively treat multiple myeloma
(MM) and other malignancies for decades. Its use has waned in recent years, however, due …
(MM) and other malignancies for decades. Its use has waned in recent years, however, due …
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho… - PloS …, 2016 - pubmed.ncbi.nlm.nih.gov
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
[PDF][PDF] Targeting Attenuated Interferon-αto Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regressionwith ReducedOff-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho… - PLoS …, 2016 - pdfs.semanticscholar.org
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.
SL Pogue, T Taura, M Bi, Y Yun, A Sho… - PLoS …, 2016 - search.ebscohost.com
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
[引用][C] Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho… - PLoS …, 2016 - ui.adsabs.harvard.edu
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent
Tumor Regression with Reduced Off-Target Activity - NASA/ADS Now on home page ads icon …
Tumor Regression with Reduced Off-Target Activity - NASA/ADS Now on home page ads icon …
[HTML][HTML] Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell… - PLoS ONE, 2016 - ncbi.nlm.nih.gov
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
[PDF][PDF] Targeting Attenuated Interferon-αto Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell - PLoS ONE, 2016 - researchgate.net
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …
Targeting Attenuated Interferon-α to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity.
SL Pogue, T Taura, M Bi, Y Yun, A Sho, G Mikesell… - Plos one, 2016 - europepmc.org
Interferon-α (IFNα) has been prescribed to effectively treat multiple myeloma (MM) and other
malignancies for decades. Its use has waned in recent years, however, due to significant …
malignancies for decades. Its use has waned in recent years, however, due to significant …